AU4818599A - Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12),md-1, md2 and cyclin e2, related reagents and methods - Google Patents

Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12),md-1, md2 and cyclin e2, related reagents and methods

Info

Publication number
AU4818599A
AU4818599A AU48185/99A AU4818599A AU4818599A AU 4818599 A AU4818599 A AU 4818599A AU 48185/99 A AU48185/99 A AU 48185/99A AU 4818599 A AU4818599 A AU 4818599A AU 4818599 A AU4818599 A AU 4818599A
Authority
AU
Australia
Prior art keywords
hsljd37r
hdtea84
dub12
dub11
hcc5
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48185/99A
Other languages
English (en)
Inventor
Elizabeth Esther Mary Bates
Jose Fernando Bazan
Daniel M. Gorman
Jonathan R. Greene
Joseph A. Hedrick
James A. Johnston
Serge J. E Lebecque
Emma M. Lees
Daniel Mahony
Jeanine D. Mattson
Nicholas J Murgolo
Erin E. Murphy
Luquan Wang
Albert Zlotnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU4818599A publication Critical patent/AU4818599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU48185/99A 1998-07-06 1999-07-06 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12),md-1, md2 and cyclin e2, related reagents and methods Abandoned AU4818599A (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US11093898A 1998-07-06 1998-07-06
US09110938 1998-07-06
US11446698A 1998-07-13 1998-07-13
US09114466 1998-07-13
US9389798P 1998-07-23 1998-07-23
US60093897 1998-07-23
US13296898A 1998-08-12 1998-08-12
US09132968 1998-08-12
US13621498A 1998-08-18 1998-08-18
US09136214 1998-08-18
US9999998P 1998-09-11 1998-09-11
US60099999 1998-09-11
PCT/US1999/012366 WO2000001817A2 (fr) 1998-07-06 1999-07-06 Genes mammiferes ; transporteur du type prostaglandine de cellules dendritiques (dc-pgt), hdtea84, hsljd37r et rankl, chimiokine hcc5, proteines de desubiquitination 11 et 12 (dub11, dub12), md-1, md-2 et cycline e2, reactifs apparentes et procedes associes

Publications (1)

Publication Number Publication Date
AU4818599A true AU4818599A (en) 2000-01-24

Family

ID=27557472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48185/99A Abandoned AU4818599A (en) 1998-07-06 1999-07-06 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12),md-1, md2 and cyclin e2, related reagents and methods

Country Status (5)

Country Link
EP (1) EP1093516A2 (fr)
JP (1) JP2002519062A (fr)
AU (1) AU4818599A (fr)
CA (1) CA2332573A1 (fr)
WO (1) WO2000001817A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU779402B2 (en) * 1999-04-12 2005-01-20 Genentech Inc. Tumor necrosis factor homologs and nucleic acids encoding the same

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5802798A (en) 1996-12-20 1998-07-17 Human Genome Sciences, Inc. Human oncogene induced secreted protein i
ATE365796T1 (de) 1997-01-14 2007-07-15 Human Genome Sciences Inc Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
US6358508B1 (en) 1997-06-11 2002-03-19 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR9
EP1012179A2 (fr) 1997-09-12 2000-06-28 Apotech R&D S.A. Recepteurs "trail" riches en cysteine
WO1999018205A1 (fr) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION
WO2000026245A2 (fr) * 1998-11-04 2000-05-11 Incyte Pharmaceuticals, Inc. Proteines de transport membranaire
AU2486300A (en) * 1998-12-30 2000-07-31 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
JP2003503052A (ja) * 1999-06-23 2003-01-28 アンジオジーン インコーポレイテッド サイクリンｅ遺伝子発現を調節するアンチセンスオリゴヌクレオチドおよび治療でのその使用
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
US6329171B1 (en) 1999-09-30 2001-12-11 Millennium Pharmaceuticals, Inc. 23484, A novel human ubiquitin protease
US7329529B2 (en) 1999-09-03 2008-02-12 Millennium Pharmaceuticals, Inc. Ubiqutin proteases
DE60042220D1 (de) * 1999-09-21 2009-06-25 Chugai Pharmaceutical Co Ltd Verwendung vom transportergen oatp-c zur screening von testsubstanzen
US6451994B1 (en) 1999-09-27 2002-09-17 Millennium Pharmaceuticals, Inc. 23413, a novel human ubiquitin protease
US7029895B2 (en) 1999-09-27 2006-04-18 Millennium Pharmaceuticals, Inc. 27411, a novel human PGP synthase
CA2391820A1 (fr) * 1999-10-22 2001-05-03 Zymogenetics, Inc. Polypeptides umlr
AU2002219083A1 (en) * 2000-11-09 2002-05-21 Bayer Aktiengesellschaft Regulation of human oat-like protein
US6900044B2 (en) 2001-03-27 2005-05-31 Millennium Pharmaceutical, Inc. 68999, a human ubiquitin carboxyl-terminal hydrolase family member and uses therefor
WO2003013583A1 (fr) * 2001-08-10 2003-02-20 Genset S.A. Agonistes et antagonistes de faxigene dans le traitement de troubles metaboliques
BR0307895A (pt) * 2002-02-22 2006-01-17 Aventis Pharma Inc Análogos humanos dos genes murinos da protease de desubiquitinação
GB0218518D0 (en) 2002-03-22 2002-09-18 Aventis Pharma Inc Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
WO2005049818A2 (fr) * 2003-11-14 2005-06-02 The Queen's University Of Belfast Gene
US7312320B2 (en) 2003-12-10 2007-12-25 Novimmune Sa Neutralizing antibodies and methods of use thereof
US7674884B2 (en) * 2003-12-10 2010-03-09 Novimmune S.A. Neutralizing antibodies and methods of use thereof
GB0412186D0 (en) * 2004-05-28 2004-06-30 Univ Cambridge Tech Production of recombinant protein
US7846438B2 (en) 2004-08-03 2010-12-07 Biogen Idec Ma Inc. Methods of promoting neurite outgrowth with soluble TAJ polypeptides
EP2776066B1 (fr) 2011-11-07 2018-09-19 Universite Laval Antagonistes de rank/rankl pour l'utilisation dans le traitement de troubles neuromusculaires, de myopathies génétiques et/ou de myopathies non génétiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ271756A (en) * 1993-12-22 1998-02-26 Human Genome Sciences Inc Human macrophage inflammatory proteins and coding sequences, their production and use
MX9708537A (es) * 1995-05-05 1998-02-28 Human Genome Sciences Inc Quimiocina beta-8 quimiocina beta-1 y proteina-4 inflamatoria de los macrofagos, humanas.
US5792851A (en) * 1996-09-03 1998-08-11 Albert Einstin College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Human prostaglandin transporter

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU779402B2 (en) * 1999-04-12 2005-01-20 Genentech Inc. Tumor necrosis factor homologs and nucleic acids encoding the same

Also Published As

Publication number Publication date
CA2332573A1 (fr) 2000-01-13
JP2002519062A (ja) 2002-07-02
WO2000001817A3 (fr) 2000-06-29
EP1093516A2 (fr) 2001-04-25
WO2000001817A2 (fr) 2000-01-13

Similar Documents

Publication Publication Date Title
AU4818599A (en) Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12),md-1, md2 and cyclin e2, related reagents and methods
ZA964776B (en) Mammalian cell culture process.
AU6019398A (en) Method for analyzing dna from a rare cell in a cell population
AU3141399A (en) Liquid fuel cell system
AU2023199A (en) Methods, systems, and kits for intravascular nucleic acid delivery
AU1406897A (en) New polymer material for electrolytic membranes in fuel cells
AU2596299A (en) Direct deposit of catalyst on the membrane of direct feed fuel cells
AU1779800A (en) Membrane suitable for electrochemical cells
AU1410399A (en) Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell
AU4270796A (en) Improvements in or relating to endometrial function
AU4451597A (en) An electrolyte system, a method for the preparation thereof, the use thereof and a battery containing the electrolyte system
ZA986051B (en) Isolated mammalian membrane protein genes related reagents
AU1152397A (en) Methods for in vivo t cell activation by antigen-pulsed dendritic cells
AU7209496A (en) Method for making an electrochemical cell, and resulting electrochemical cell
AU2805395A (en) Dna, constructs, cells and plants derived therefrom
AU6229498A (en) Composition for gene introduction into cell
WO1996007739A3 (fr) Recepteurs de type 3 de l'interleukine 1
WO2000029551A3 (fr) Cellules, procedes de culture et leurs utilisations
AU2667995A (en) Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells
AU5495194A (en) Flow through membrane nucleic acid hybridization assay
ZA971081B (en) Mammalian dendritic cell chemokine reagents.
AU6329796A (en) Separator for alkaline electrochemical cells
AU1531695A (en) Electro-chemical cell
AU3063699A (en) Isolated mammalian membrane protein genes and related reagents
AU7233494A (en) Dna, constructs, cells and plants derived therefrom

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase